SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001640334-24-000086
Filing Date
2024-01-18
Accepted
2024-01-18 14:38:18
Documents
9
Effectiveness Date
2024-01-18

Document Format Files

Seq Description Document Type Size
1 FORM S-8 lxrp_s8.htm S-8 149562
2 EQUITY INCENTIVE PLAN lxrp_ex41.htm EX-4.1 90043
3 OPINION OF SICHENZIA lxrp_ex51.htm EX-5.1 6161
4 CONSENT lxrp_ex232.htm EX-23.2 2078
5 CONSENT lxrp_ex233.htm EX-23.3 3242
6 FILING FEE TABLE lxrp_ex107.htm EX-FILING FEES 16036
7 lxrp_ex51img1.jpg GRAPHIC 7061
8 lxrp_s8img1.jpg GRAPHIC 14407
9 lxrp_ex233img1.jpg GRAPHIC 4324
  Complete submission text file 0001640334-24-000086.txt   304231
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: S-8 | Act: 33 | File No.: 333-276584 | Film No.: 24541383
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)